[Surgical treatment of gastric cancer in stage T1/T2: an reevaluation of the clinical significance of early gastric cancer].
OBJECTIVE
To evaluate the clinical significance of early gastric cancer by means of an analysis of the results of surgical treatment of gastric cancer in stage T1/T2.


METHODS
A retrospective review and survival analysis of 132 patients with stage T1/T2 stomach cancer treated from 1983 through 1993 was performed.


RESULTS
The average tumor size, lymph node involvement, postoperative recurrence and survival rate were significantly different between gastric cancer in stage T1 and T2. It was true of both groups of patients that the survival rate of patients with and without lymph node involvement was significantly different. However, the survival rate of patients in stage T2 but without lymph node involvement was not significantly different as compared to that of patients in stage T1.


CONCLUSIONS
For stage T1 stomach cancer, because of possible lymph node involvemnt, local mucosal excision of tumor is not recommended. For stage T2 stomach cancer without lymph node metastasis, it can be regarded as cancer still in its early stage when postoperative adjunct therapy is to be given.
Yuan
X
X
Cancer Institute (Hospital), Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100021.
Cui
X
X
Zheng
C
C
D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D013274:Stomach Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D015996:Survival Rate